Getein Biotech Inc (603387) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Getein Biotech Inc (603387) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.90 Million ≈ $14.76 Million USD) by net assets (CN¥2.80 Billion ≈ $409.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603387 equity financing ratio to measure how much of total assets are equity-financed.

Getein Biotech Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Getein Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Getein Biotech Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Getein Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Getein Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
JSE Limited JSE:JSE	0.140x
Shenzhen Sea Star Technology SHE:002137	0.031x
MCAN Mortgage Corporation TO:MKP	0.033x
Washington Trust Bancorp Inc NASDAQ:WASH	0.041x
Weebit Nano Ltd AU:WBT	-0.109x
Beijing North Star Co Ltd Class A SHG:601588	0.076x
Shenzhen Xunjiexing Technology Corp. Ltd. SHG:688655	-0.007x
Zhejiang Zhongcheng Packing Material Co Ltd SHE:002522	0.020x

Annual Cash Flow Conversion Efficiency for Getein Biotech Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Getein Biotech Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 603387 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.86 Billion ≈ $418.42 Million	CN¥392.59 Million ≈ $57.45 Million	0.137x	-11.68%
2024-12-31	CN¥2.72 Billion ≈ $398.16 Million	CN¥423.00 Million ≈ $61.90 Million	0.155x	+27.89%
2023-12-31	CN¥2.74 Billion ≈ $401.13 Million	CN¥333.22 Million ≈ $48.76 Million	0.122x	-32.93%
2022-12-31	CN¥2.66 Billion ≈ $389.91 Million	CN¥482.96 Million ≈ $70.67 Million	0.181x	-4.67%
2021-12-31	CN¥2.27 Billion ≈ $332.76 Million	CN¥432.36 Million ≈ $63.27 Million	0.190x	+105.44%
2020-12-31	CN¥2.00 Billion ≈ $293.25 Million	CN¥185.47 Million ≈ $27.14 Million	0.093x	-31.05%
2019-12-31	CN¥1.68 Billion ≈ $246.08 Million	CN¥225.73 Million ≈ $33.03 Million	0.134x	-0.76%
2018-12-31	CN¥1.38 Billion ≈ $202.40 Million	CN¥187.10 Million ≈ $27.38 Million	0.135x	-19.10%
2017-12-31	CN¥1.15 Billion ≈ $167.95 Million	CN¥191.91 Million ≈ $28.08 Million	0.167x	-63.22%
2016-12-31	CN¥342.96 Million ≈ $50.19 Million	CN¥155.91 Million ≈ $22.82 Million	0.455x	+0.31%
2015-12-31	CN¥268.60 Million ≈ $39.30 Million	CN¥121.73 Million ≈ $17.81 Million	0.453x	-24.02%
2014-12-31	CN¥165.19 Million ≈ $24.17 Million	CN¥98.53 Million ≈ $14.42 Million	0.596x	-16.03%
2013-12-31	CN¥84.06 Million ≈ $12.30 Million	CN¥59.72 Million ≈ $8.74 Million	0.710x	+21.27%
2012-12-31	CN¥40.63 Million ≈ $5.95 Million	CN¥23.80 Million ≈ $3.48 Million	0.586x	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$665.69 Million

CN¥4.55 Billion CNY

Market Cap Rank

#10790 Global

#2941 in China

Share Price

CN¥8.97

Change (1 day)

+0.79%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49